Pre-order Enquiry
Request Free Sample
Global Anti-Tumor Drugs Market Outlook 2022
SKU ID : QYR-19602456 | Publishing Date : 26-Nov-2021
Request Sample
Request Customization
Check Discounts
Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It has been observed that cancer is second leading cause of deaths in Europe and North America. To treat these tumor growth, anti tumor drugs are considered as of one of the key therapy which has been accepted worldwide.
The market is concentrated in the North American region and together with Europe accounts for over 60% of the market share. The Asian and African economies possess a substantial growth opportunity owing to high cancer mortalities and bleak availability of effective drugs. Chinese and Japanese drug manufacturers dominate the Asian market with over 60% of the regional share.
The global Anti-Tumor Drugs market was valued at US$ 94340 million in 2020 and is expected to reach US$ 126230 million by the end of 2027, growing at a CAGR of 4.2% during 2021-2027.
This report focuses on Anti-Tumor Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anti-Tumor Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Anti-Tumor Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
Segment by Application
Hospital Use
Clinic Use
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Roche
Novartis
Celgene
The market is concentrated in the North American region and together with Europe accounts for over 60% of the market share. The Asian and African economies possess a substantial growth opportunity owing to high cancer mortalities and bleak availability of effective drugs. Chinese and Japanese drug manufacturers dominate the Asian market with over 60% of the regional share.
The global Anti-Tumor Drugs market was valued at US$ 94340 million in 2020 and is expected to reach US$ 126230 million by the end of 2027, growing at a CAGR of 4.2% during 2021-2027.
This report focuses on Anti-Tumor Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anti-Tumor Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Anti-Tumor Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
Segment by Application
Hospital Use
Clinic Use
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Roche
Novartis
Celgene
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
